TREAT PTSD Act
12/14/2023, 8:15 AMSummary of Bill HR 3023
Bill 118 hr 3023, also known as the TREAT PTSD Act, is a piece of legislation currently being considered by the US Congress. The purpose of this bill is to improve the treatment and care for individuals suffering from Post-Traumatic Stress Disorder (PTSD).The TREAT PTSD Act aims to achieve this goal by increasing funding for research into PTSD, as well as expanding access to mental health services for those affected by the disorder. The bill also seeks to enhance training for healthcare providers in recognizing and treating PTSD, in order to ensure that individuals receive the best possible care.
Additionally, the TREAT PTSD Act includes provisions for the development of new and innovative treatment options for PTSD, with the goal of improving outcomes for those struggling with the disorder. The bill also emphasizes the importance of early intervention and prevention strategies, in order to address PTSD before it becomes a more serious issue. Overall, the TREAT PTSD Act is a comprehensive piece of legislation that seeks to address the needs of individuals suffering from PTSD, by improving access to care, increasing research funding, and promoting early intervention strategies. If passed, this bill has the potential to make a significant impact on the lives of those affected by PTSD.
Congressional Summary of HR 3023
Treatment and Relief through Emerging and Accessible Therapy for PTSD Act or the TREAT PTSD Act
This bill requires the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to furnish stellate ganglion block to certain veterans or members of the Armed Forces (including reserve components) diagnosed with post-traumatic stress disorder (PTSD). Blocking the stellate ganglion (a group of nerves at the base of the neck) by injecting a local anesthetic is a treatment that may alleviate PTSD symptoms.
The bill authorizes this treatment for any veteran or member of the Armed Forces who (1) is enrolled in the VA health care system or TRICARE program, (2) has been diagnosed with PTSD, and (3) has elected to receive stellate ganglion block after being informed by a physician of the risks and benefits. Such treatment may be furnished at a VA medical center, DOD medical facility, or through health care provider under the Veterans Community Care Program or TRICARE health insurance program.
The bill also requires the VA and DOD to update the VA/DOD Clinical Practice Guideline (CPG) for the Management of PTSD to ensure that information about stellate ganglion block is included.
